title: Survival rate of childhood leukemia in shiraz, southern iran.
abstract: OBJECTIVE
  Leukemia is the most prevalent type of cancer in children. The aim of this study was to estimate the 5-year survival rates of Acute Lymphoblastic Leukemia (ALL) and Acute Myeloblastic Leukemia (AML) as well as factors influencing them.
  
  
  METHODS
  This is a nonrandomized retrospective study conducted on 280 patients with ALL and AML. They were all below 15 years old children admitted to Shahid Faghihi hospital, Shiraz, Iran from 2004 to 2008.The survival rates were estimated by applying the Kaplan-Meier method. In addition, the log rank test was used to estimate the statistical significance of differences in the survival probability. Cox regression model was applied to conduct multivariate analysis for adjusting confounding variable. All analyses were performed in SPSS statistical software (version 16). P-values less than 0.05 were considered as statistically significant.
  
  
  RESULTS
  The mean (± standard deviation) of the observation period was 28.2±16.1 months. In this period, 60 (24.7%) patients (47 ALL and 15 AML) passed away. The cumulative rate of survival in this study was 53.3±0.1 percent. This probability was 56.6±0.1% and 44.2±0.1% for ALL and AML patients, respectively, which indicates no statistically significant difference between them (P=0.8). According to Cox model, there was a significant relationship among the variables of platelet count and relapse with the survival rate.
  
  
  CONCLUSIONS
  Platelet count was identified as a positive prognostic factor of the survival rate in ALL patients. However, on the base of our results and other studies, incidence of relapse and the number of relapses are significant factors of survival rates of leukemia.
authors.affiliation: Department of Public Health, School of Health, Arak University of Medical Sciences, Arak, Iran.
authors.forename: Almasi-Hashiani
authors.initials: AH
authors.lastname: Amir
authors.forename: Zareifar
authors.initials: Z
authors.lastname: Soheil
authors.forename: Karimi
authors.initials: K
authors.lastname: Mehran
authors.forename: Khedmati
authors.initials: K
authors.lastname: Esmaeil
authors.forename: Mohammadbeigi
authors.initials: M
authors.lastname: Abolfazl
keywords: Lymphoblastic Leukemia; Myeloblastic Leukemia; Relapse; Survival Rate
references.citation: Cancer Causes Control. 2002 Feb;13(1):15-25
references.pmid: 11899114
references.citation: Int J Hematol. 2007 Jan;85(1):36-40
references.pmid: 17261500
references.citation: Eur J Cancer. 2006 Mar;42(4):534-41
references.pmid: 16412629
references.citation: Cancer Detect Prev. 2008;32(2):178-83
references.pmid: 18632219
references.citation: Eur J Cancer. 2006 Sep;42(13):1972-80
references.pmid: 16919765
references.citation: Int J Cancer. 2008 Jun 1;122(11):2607-11
references.pmid: 18324630
references.citation: Environ Health Perspect. 2007 Jan;115(1):138-45
references.pmid: 17366834
references.citation: Eur J Cancer. 2001 Apr;37(6):687-94
references.pmid: 11311642
references.citation: Med Pediatr Oncol. 2002 Apr;38(4):229-39
references.pmid: 11920786
references.citation: Eur J Cancer. 2008 Jan;44(2):205-15
references.pmid: 18077152
references.citation: Paediatr Perinat Epidemiol. 2006 Jul;20(4):312-22
references.pmid: 16879503
references.citation: Eur J Cancer. 2001 Apr;37(6):695-702
references.pmid: 11311643
references.citation: Eur J Cancer. 2008 Jun;44(9):1282-9
references.pmid: 18430564
references.citation: Hematology Am Soc Hematol Educ Program. 2004;:118-45
references.pmid: 15561680
references.citation: Med Sci Monit. 2002 Dec;8(12):CR792-6
references.pmid: 12503037
references.citation: Eur J Cancer. 2003 May;39(7):952-60
references.pmid: 12706364
references.citation: J Pediatr Hematol Oncol. 2004 Aug;26(8):507-14
references.pmid: 15284589